Chronic pain study in severe hemophilia A
Part of Blood & lymphatic, Genetic & congenital, Pain clinical trials.
This study looks at chronic pain in people with severe hemophilia A. It aims to understand pain better through questionnaires and joint health checks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have severe hemophilia A (factor VIII less than 1%).
- You do not have inhibitors to factor VIII right now.
- You have been on bispecific antibody treatment for at least 3 months.
- You have joint damage in at least two lower-limb joints with a score of 5 or more on the Haemophilia Joint Health Score.
- You can understand and fill out questionnaires on your own.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an educational program can help patients with hemophilia-related joint damage manage chronic pain better. If you have hemophilia A or B, painful joints, and want to learn new pain coping skills, this study may be a good fit.
This trial uses ultrasound to check if healthy joints in people with hemophilia A develop damage while being treated with emicizumab (Hemlibra). It looks at elbows, knees, and ankles over time to see if the medicine prevents joint problems.
This study looks at how prophylactic treatment for hemophilia affects your daily life, sleep, and feelings about your health. It compares different types of clotting factor concentrates to see if one is easier to manage than the other.
This study looks at how many adults with moderate or severe hemophilia A have inflammation in their joints (synovitis). It aims to better understand joint health in people with hemophilia A, including those with inhibitors or joint replacements.
This study checks joint health and bleeding risk in people with severe hemophilia A who are taking newer factor VIII treatments or emicizumab. It uses ultrasound and blood tests to see how well these therapies protect joints.
This study compares a rehabilitation program you can do at home using video calls (telerehabilitation) with in-person rehabilitation sessions. The goal is to see if the home-based option works as well as office visits for reducing chronic joint pain in adults with hemophilia.
Hear when a new Hemophilia A Without Inhibitor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.